Valuation Torrent Pharmaceuticals Limited

Stocks

Delayed Bombay S.E. 05:44:41 2026-08-20 EDT			5-day change	1st Jan Change
4,990.00 ^INR	-0.46%		+2.33%	+29.89%

07-30	Torrent Pharmaceuticals Limited, Q1 2027 Earnings Call, Jul 30, 2026
07-30	Torrent Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	473,197	520,309	880,347	1,094,736	1,428,460	1,906,784	-	-
Change	-	9.96%	69.2%	24.35%	30.48%	33.49%	-	-
Enterprise Value (EV) ¹	508,027	566,719	910,767	1,119,846	1,564,790	2,028,788	2,000,385	1,964,844
Change	-	11.55%	60.71%	22.96%	39.73%	29.65%	-1.4%	-1.78%
P/E	60.9x	57.4x	53.1x	57.3x	66x	74.5x	53.9x	43.4x
PBR	7.95x	8.4x	12.8x	14.4x	17x	13.3x	11.4x	9.85x
PEG	-	3.4x	0.6x	3.7x	5x	13.97x	1.4x	1.8x
Capitalization / Revenue	5.56x	5.41x	8.21x	9.51x	10.2x	9.63x	8.56x	7.64x
EV / Revenue	5.97x	5.89x	8.49x	9.72x	11.2x	10.2x	8.98x	7.87x
EV / EBITDA	20.9x	19.9x	27x	30.1x	34.3x	30.5x	25.7x	22.1x
EV / EBIT	28.7x	26.5x	34.4x	38.3x	45.5x	46.4x	36.9x	30.3x
EV / FCF	31.8x	31.6x	32.1x	56.7x	66.7x	51.6x	36.7x	32.5x
FCF Yield	3.15%	3.17%	3.11%	1.76%	1.5%	1.94%	2.73%	3.08%
Dividend per Share ²	16.5	22	28	32	38	32.7	38.18	46.78
Rate of return	1.18%	1.43%	1.08%	0.99%	0.9%	0.65%	0.76%	0.93%
EPS ²	22.96	26.79	48.94	56.47	63.92	67.33	92.92	115.4
Distribution rate	71.8%	82.1%	57.2%	56.7%	59.4%	48.6%	41.1%	40.5%
Net sales ¹	85,080	96,200	107,280	115,160	139,800	198,060	222,820	249,657
EBITDA ¹	24,310	28,420	33,680	37,210	45,590	66,600	77,800	89,023
EBIT ¹	17,690	21,350	26,480	29,260	34,400	43,718	54,154	64,773
Net income ¹	7,770	12,450	16,560	19,110	21,630	24,722	34,254	43,639
Net Debt ¹	34,830	46,410	30,420	25,110	136,330	122,003	93,601	58,060
Reference price ²	1,398.15	1,537.35	2,601.15	3,234.60	4,220.65	5,013.00	5,013.00	5,013.00
Nbr of stocks (in thousands)	338,445	338,445	338,445	338,445	338,445	380,368	-	-
Announcement Date	5/25/22	5/30/23	5/24/24	5/20/25	5/22/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
TORRENT PHARMACEUTICALS LIMITED	74.45x	10.24x	30.46x	0.65%	19.95B
ELI LILLY AND COMPANY	36.57x	13.2x	26.79x	0.54%	1,141B
JOHNSON & JOHNSON	30.41x	-	-	1.96%	659B
ABBVIE INC.	33.95x	7.85x	16.34x	2.58%	470B
ROCHE HOLDING AG	20.47x	4.85x	12.03x	2.72%	366B
NOVARTIS AG	22.39x	5.8x	14.38x	2.75%	302B
ASTRAZENECA PLC	21x	4.33x	12.29x	2.03%	254B
AMGEN INC.	27.98x	7.21x	12.8x	2.28%	239B
NOVO NORDISK A/S	13.62x	4.84x	10.15x	3.77%	207B
GILEAD SCIENCES, INC.	-45.1x	6.51x	25.42x	2.23%	183B
Average	23.58x	7.20x	17.85x	2.15%	384.09B
Weighted average by Cap.	26.05x	8.64x	19.03x	1.88%